STING1 and neoplasm: ROC1-tumor cells were injected into the tongues of immunocompetent C57BL/6 mice, which were randomized to receive PBS, the STING agonist, a PBS/IgG2a isotype control, or anti–PD-1 antibody plus the STING agonist.